How was the price per share determined for Peter C. Wallace’s Curtiss-Wright (CW) grant?

The filing notes a price based on the New York Stock Exchange closing market price for Curtiss-Wright shares on June 1, 2026. That date aligns with when Wallace elected to receive this installment of his deferred restricted stock compensation.

Curtiss-Wright (NYSE: CW) director receives 221 deferred stock shares

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Wallace Peter C reported acquisition or exercise transactions in this Form 4 filing.

Curtiss-Wright director Peter C. Wallace reported receiving 221 shares of common stock as a deferred restricted stock award. The shares were issued under the company’s 2024 Omnibus Incentive Plan as part of his non-employee director compensation. Following this grant, he directly holds 6,209 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wallace Peter C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	221	$719.99	$159K

Holdings After Transaction: Common Stock — 6,209 shares (Direct, null)

Footnotes (1)

Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock at a later date. Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred to June 1, 2025. Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the Reporting Person's restricted stock award as the reporting person elected to receive the restricted stock in five equal installments beginning June 1, 2025. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of June 1, 2026. The date recipient elected to receive his shares.

Key Figures

Shares granted: 221 shares Price per share (grant basis): $719.99 per share Holdings after transaction: 6,209 shares +3 more

6 metrics

Shares granted 221 shares Restricted stock grant on June 1, 2026

Price per share (grant basis) $719.99 per share Closing market price on June 1, 2026

Holdings after transaction 6,209 shares Total direct Curtiss-Wright common stock after grant

Original award value $125,000 Board-approved restricted stock award value in February 2021

Original pricing reference $115.24 per share NY Stock Exchange closing price on February 16, 2021

Portion of total award 20% One of five equal installments of restricted stock

Key Terms

2024 Omnibus Incentive Plan, restricted stock award, defer their compensation, dividend credits

4 terms

2024 Omnibus Incentive Plan financial

"Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation"

restricted stock award financial

"Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

defer their compensation financial

"non-employee directors may elect to defer their compensation, including their annual restricted stock award"

dividend credits financial

"The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/02/2026 - 04:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wallace Peter C

(Last)

(First)

(Middle)

C/O CURTISS-WRIGHT CORPORATION

130 HARBOUR PLACE DRIVE

(Street)

DAVIDSON

NORTH CAROLINA

28036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		A⁽¹⁾		221⁽²⁾	A	$719.99⁽³⁾	6,209	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock at a later date.

2. Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred to June 1, 2025. Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the Reporting Person's restricted stock award as the reporting person elected to receive the restricted stock in five equal installments beginning June 1, 2025.

3. Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of June 1, 2026. The date recipient elected to receive his shares.

Remarks:

	George P. McDonald by Power of Attorney for Peter C. Wallace	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Curtiss-Wright (CW) report for Peter C. Wallace?

Curtiss-Wright reported that director Peter C. Wallace received 221 shares of common stock as a grant under the 2024 Omnibus Incentive Plan. The award reflects deferred director compensation and is structured as restricted stock, not an open-market purchase or sale.

How many Curtiss-Wright (CW) shares does Peter C. Wallace hold after this Form 4?

After this transaction, Peter C. Wallace directly holds 6,209 shares of Curtiss-Wright common stock. The 221-share grant increased his existing position and represents part of a deferred restricted stock award tied to earlier board-approved compensation.

What is the origin and value basis of Peter C. Wallace’s Curtiss-Wright (CW) award?

The award was originally valued at $125,000 and approved in February 2021. The number of shares was calculated using a $115.24 closing price on that approval date, then rounded and adjusted for dividend credits as part of a deferred restricted stock structure.

How is the Curtiss-Wright (CW) restricted stock award to Peter C. Wallace structured over time?

The reported 221 shares represent 20% of Wallace’s restricted stock award, which he elected to receive in five equal installments. This filing reflects one installment, with the receipt scheduled according to his deferral election and the company’s director compensation plan.